Bioluminescence imaging of angiogenesis in a murine orthotopic pancreatic cancer model

Molecular Imaging and Biology

Volumn 12, Issue 6, 2010, Pages 570-575

  Angst, Eliane ^a,b   Chen, Monica ^a   Mojadidi, Michelle ^a   Hines, O Joe ^a   Reber, Howard A ^a   Eibl, Guido ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Angiogenesis; Bioluminescence; Pancreatic cancer; VEGFR2

Indexed keywords

CD31 ANTIGEN; LUCIFERASE; LUCIFERIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CANCER GRAFT; CANCER GROWTH; CANCER MODEL; CARCINOGENESIS; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DNA MODIFICATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR VASCULARIZATION; WOUND HEALING;

ANIMALS; CARCINOMA; CELLS, CULTURED; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; HUMANS; LUMINESCENT PROTEINS; MALE; MICE; MICE, NUDE; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HETEROTOPIC;

MURINAE;

EID: 78650511891     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-010-0310-4     Document Type: Article

References (29)

1. J Folkman 2007 Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6 273 286 1:CAS:528:DC%2BD2sXjs1SisL4%3D 10.1038/nrd2115 17396134 (Pubitemid 46505878)
2. GN Naumov LA Akslen J Folkman 2006 Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch Cell Cycle 5 1779 1787 1:CAS:528:DC%2BD28Xht1Gnt7rL 10.4161/cc.5.16.3018 16931911 (Pubitemid 44435320)
3. Matsumoto T, Claesson-Welsh L (2001) VEGF receptor signal transduction Sci STKE 2001: RE21
4. M Shibuya L Claesson-Welsh 2006 Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis Exp Cell Res 312 549 560 1:CAS:528:DC%2BD28XhvVWltbo%3D 10.1016/j.yexcr.2005.11.012 16336962 (Pubitemid 43290332)
5. F Shalaby J Rossant TP Yamaguchi, et al. 1995 Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice Nature 376 62 66 1:CAS:528:DyaK2MXmvVKjsro%3D 10.1038/376062a0 7596435
6. E Hatva A Kaipainen P Mentula, et al. 1995 Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors Am J Pathol 146 368 378 1:STN:280:DyaK2M7mtVWgtw%3D%3D 7856749
7. S Rousseau F Houle H Kotanides, et al. 2000 Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase J Biol Chem 275 10661 10672 1:CAS:528:DC%2BD3cXisFWjurk%3D 10.1074/jbc.275.14.10661 10744763 (Pubitemid 30202134)
8. K Holmes OL Roberts AM Thomas MJ Cross 2007 Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition Cell Signal 19 2003 2012 1:CAS:528:DC%2BD2sXovFylsLs%3D 10.1016/j.cellsig.2007.05.013 17658244 (Pubitemid 47354167)
9. G Eibl HA Reber 2005 A xenograft nude mouse model for perineural invasion and recurrence in pancreatic cancer Pancreas 31 258 262 10.1097/01.mpa. 0000175176.40045.0f 16163058 (Pubitemid 41400484)
10. EI Korpelainen MJ Karkkainen A Tenhunen, et al. 1998 Overexpression of VEGF in testis and epididymis causes infertility in transgenic mice: evidence for nonendothelial targets for VEGF J Cell Biol 143 1705 1712 1:CAS:528:DyaK1MXhsFU%3D 10.1083/jcb.143.6.1705 9852161 (Pubitemid 29006513)
11. F Aucejo R Kim N Zein, et al. 2009 Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic liver is higher when hepatoma is beyond Milan criteria Liver Transplant 15 169 176 10.1002/lt.21678
12. D Fukumura RK Jain 2008 Imaging angiogenesis and the microenvironment Apmis 116 695 715 1:CAS:528:DC%2BD1cXht1CjsbzO 10.1111/j.1600-0463.2008.01148.x 18834413
13. JK Willmann K Chen H Wang, et al. 2008 Monitoring of the biological response to murine hindlimb ischemia with 64Cu-labeled vascular endothelial growth factor-121 positron emission tomography Circulation 117 915 922 1:CAS:528:DC%2BD1cXhsFCru7k%3D 10.1161/CIRCULATIONAHA.107.733220 18250264 (Pubitemid 351272589)
14. J Virostko J Xie DE Hallahan CL Arteaga JC Gore HC Manning 2009 A molecular imaging paradigm to rapidly profile response to angiogenesis-directed therapy in small animals Mol Imaging Biol 11 204 212 10.1007/s11307-008-0193-9 19130143
15. G Korpanty JG Carbon PA Grayburn JB Fleming RA Brekken 2007 Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature Clin Cancer Res 13 323 230 1:CAS:528:DC%2BD2sXotlag 10.1158/1078-0432.CCR-06- 1313 17200371 (Pubitemid 46121886)
16. M Palmowski J Huppert G Ladewig, et al. 2008 Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects Mol Cancer Ther 7 101 109 1:CAS:528: DC%2BD1cXmsVyhsw%3D%3D 10.1158/1535-7163.MCT-07-0409 18202013
17. ME Loveless JG Whisenant K Wilson, et al. 2009 Coregistration of ultrasonography and magnetic resonance imaging with a preliminary investigation of the spatial colocalization of vascular endothelial growth factor receptor 2 expression and tumor perfusion in a murine tumor model Mol Imaging 8 187 198 1:CAS:528:DC%2BD1MXhtF2jurbM 19728973
18. YS Choe KH Lee 2007 Targeted in vivo imaging of angiogenesis: present status and perspectives Curr Pharm Des 13 17 31 1:CAS:528:DC%2BD2sXht1Wjsrg%3D 10.2174/138161207779313812 17266586 (Pubitemid 46085299)
19. JK Willmann Z Cheng C Davis, et al. 2008 Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice Radiology 249 212 219 10.1148/radiol.2491072050 18695212
20. Y Amoh K Katsuoka RM Hoffman 2008 Color-coded fluorescent protein imaging of angiogenesis: the AngioMouse models Curr Pharm Des 14 3810 3819 1:CAS:528:DC%2BD1MXhsVCitbs%3D 10.2174/138161208786898644 19128234
21. T Troy D Jekic-McMullen L Sambucetti B Rice 2004 Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models Mol Imaging 3 9 23 1:CAS:528:DC%2BD2cXkslGjsLs%3D 10.1162/153535004773861688 15142408
22. N Zhang Z Fang PR Contag AF Purchio DB West 2004 Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse Blood 103 617 626 1:CAS:528:DC%2BD2cXmsFChsA%3D%3D 10.1182/blood-2003-06-1820 14512298 (Pubitemid 38140096)
23. Lyons S, Clermont A, Neben T et al (2005) Non-invasive in vivo bioluminescent imaging of tumor angiogenesis in mice. AACR 96th Annual Meeting
24. Lyons S, Lim E, Chen M et al (2006) Non-invasive in vivo bioluminescent imaging of tumor angiogenesis in mice. Society for Molecular Imaging-5th Annual Meeting
25. HG Hotz OJ Hines R Masood, et al. 2005 VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer Surgery 137 192 199 10.1016/j.surg.2004.07.015 15674201 (Pubitemid 40174428)
26. P Buchler HA Reber M Buchler, et al. 2003 Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer Pancreas 26 56 64 1:CAS:528:DC%2BD3sXns1SntLo%3D 10.1097/00006676- 200301000-00010 12499918 (Pubitemid 36020267)
27. JP Duffy G Eibl HA Reber OJ Hines 2003 Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer Mol Cancer 2 12 10.1186/1476-4598-2-12 12605718 (Pubitemid 38751485)
28. P Buchler HA Reber MW Buchler H Friess RS Lavey OJ Hines 2004 Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression Cancer 100 201 210 1:CAS:528:DC%2BD2cXkslektA%3D%3D 10.1002/cncr.11873 14692041 (Pubitemid 37553556)
29. HL Kindler G Friberg DA Singh, et al. 2005 Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer J Clin Oncol 23 8033 8040 1:CAS:528:DC%2BD2MXht1CqsL%2FE 10.1200/JCO.2005.01.9661 16258101 (Pubitemid 46657405)